← Open Payments lookup

ALLISON COTHERN: Open Payments

NPI 1013539832 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,495 in 71 payments from 24 companies in 2025. Trend: 2023 $1,376 · 2024 $944 · 2025 $1,495

Food & beverage: $1,495
CompanyPaymentsAmount
Novo Nordisk Inc11$215
AstraZeneca Pharmaceuticals LP8$192
PFIZER INC.5$109
GlaxoSmithKline, LLC.5$86
Corcept Therapeutics2$79
Boehringer Ingelheim Pharmaceuticals, Inc.4$79
Astellas Pharma US Inc5$78
Otsuka America Pharmaceutical, Inc.3$77
SANOFI-AVENTIS U.S. LLC3$70
Dexcom, Inc.3$69

Products named: FARXIGA, Ozempic, JARDIANCE, Wegovy, Korlym, Veozah, REXULTI, TZIELD.

Industry payments across TX — which companies pay providers there.